ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3162

Symmetric and Asymmetric Sacroiliitis Are Associated with Different Major Histocompatibility Class I Alleles in Psoriatic Arthritis

Jon T. Giles1, Muhammad Haroon2, Deepak R. Jadon3, Raj Sengupta4, Alison L Nightingale5, Eleanor Korendowych3, Jing Bi6, Neil J. McHugh3, Oliver FitzGerald7 and Robert Winchester6, 1Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 2Rheumatology, Kerry General Hospital, Co Kerry, Ireland, 3Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 4Rheumatology, Royal National Hospital for Rheumatic Diseases,, Bath, United Kingdom, 5Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, 6Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 7St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: axial spondyloarthritis, genetics, psoriatic arthritis and risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: HLA-B27 has been linked to sacroiliitis (SII) in psoriatic arthritis (PsA); however, the contribution to SII of other human leukocyte antigen (HLA) Class I loci encoding the major histocompatibility complex (MHC) has received little study.  In particular, whether symmetric and asymmetric SII are differentially genetically determined.  

Methods: Patients from two prospective PsA cohorts were genotyped for HLA-B and C alleles.  Radiographs were evaluated for SII, which was defined as symmetric (symSII) or asymmetric (asymSII) without knowledge of HLA-B and C status.   Associations of alleles with SII were explored in multivariable logistic regression models adjusting for potentially confounding characteristics.  From these models, allele scores were constructed as the sum of an individual’s positively associated alleles minus the sum of their inversely associated alleles  

Results: A total of 490 PsA patients were studied [mean age=56 years, 54% female, median PsA duration=18 years].  SymSII and asymSII was observed in 44 (9%) and 75 (15%), respectively.  In multivariable analysis, symSII was associated with 11 alleles (listed in Fig1).  SymSII was observed in 3% of patients with a symSII allele score of -3 or -2 compared with 12% of those with a score of 0 (OR=4.05; p=0.009) and in 69% of those with a score of +2 (OR=68.4; p<0.001) (Fig1A).  The area under the receiver operator curve (AUC) for detecting symSII with the allele score was 0.758 (95% CI 0.679, 0.836).  Adjusting for body mass index and PsA duration did not substantially alter the associations.                 A different set of five alleles was associated with asymSII (listed in Fig 1).  The prevalence of asymSII was 7% for those with an asymSII allele score of 0 compared with 18% for those with a score of +1 (OR=3.17; p<0.001) and 42% for those with a score of +2 or +3 (OR=10.18; p<0.001) (Fig1B).  The area under the receiver operator curve (AUC) for detecting asymSII with the allele score was 0.684 (95% CI 0.624, 0.742).  Adjusting for family history of psoriasis, current PASI score, and the presence of radiographic osteolysis did not substantially alter the associations.

Conclusion: Symmetric and asymmetric SII are differentially genetically determined, such that the determination of HLA Class I alleles may be useful in predicting risk for SII within a given PsA patient.


Disclosure: J. T. Giles, None; M. Haroon, None; D. R. Jadon, None; R. Sengupta, None; A. L. Nightingale, None; E. Korendowych, None; J. Bi, None; N. J. McHugh, None; O. FitzGerald, None; R. Winchester, None.

To cite this abstract in AMA style:

Giles JT, Haroon M, Jadon DR, Sengupta R, Nightingale AL, Korendowych E, Bi J, McHugh NJ, FitzGerald O, Winchester R. Symmetric and Asymmetric Sacroiliitis Are Associated with Different Major Histocompatibility Class I Alleles in Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/symmetric-and-asymmetric-sacroiliitis-are-associated-with-different-major-histocompatibility-class-i-alleles-in-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/symmetric-and-asymmetric-sacroiliitis-are-associated-with-different-major-histocompatibility-class-i-alleles-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology